<p>Yael Waknine of Univadis speaks with Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, about the FDA's opioid deprescribing guidelines and why tapering the medications has to be done as carefully as prescribing them in the first place.</p>

Yael Waknine of Univadis speaks with Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, about the FDA's opioid deprescribing guidelines and why tapering the medications has to be done as carefully as prescribing them in the first place.

Univadis Practice Changers: FDA's opioid deprescribing guidelines

If you're a family medicine physician or other primary care clinician, you know how hard it is to keep up with the latest research. The Univadis Practice Changers podcast provides expert analysis on the most essential new evidence in medicine. In 5 minutes or less, you'll hear experts go beyond the details of the latest study to the real-world clinical applications. Univadis Practice Changers is a quick look at essential evidence changing your daily practice.

Share Univadis Practice Changers: FDA's opioid deprescribing guidelines

Sign up to save your podcasts

Univadis Practice Changers: FDA's opioid deprescribing guidelines

Univadis Practice Changers: FDA's opioid deprescribing guidelines